MYDA Advisors’s VYNE Therapeutics VYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,296
Closed -$161K 143
2020
Q2
$161K Buy
+1,296
New +$161K 0.1% 73